243
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

End-of-treatment 18F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score

, , , , , & show all
Pages 2890-2898 | Received 15 Feb 2021, Accepted 19 Jun 2021, Published online: 05 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David A. Russler-Germain, Brendan R. Calhoun, Ningying Wu, Marcus P. Watkins, Barry A. Siegel, Nancy L. Bartlett & Joyce C. Mhlanga. (2023) FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma. Leukemia & Lymphoma 64:11, pages 1870-1874.
Read now
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F. Elliott, Thomas Witzig, Laurie H. Sehn, Marek Trnĕný, Umberto Vitolo, Maurizio Martelli, Margaret Foster, Barbara Wendelberger, Grzegorz Nowakowski & Donald A. Berry. (2022) PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & Lymphoma 63:12, pages 2816-2831.
Read now

Articles from other publishers (1)

Kelsey L. Pomykala, Wolfgang P. Fendler, Ophir Vermesh, Lale Umutlu, Ken Herrmann & Robert Seifert. (2023) Molecular Imaging of Lymphoma: Future Directions and Perspectives. Seminars in Nuclear Medicine 53:3, pages 449-456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.